Advancing synthetic biology with engineered chemically inducible gene regulatory systems

Chemically inducible gene regulatory systems, with inducible promoters as their core regulatory elements, are central to advancing synthetic biology by enabling precise, dynamic, and orthogonal control of gene expression in response to chemical signals. Recent advances have moved the field from the direct use of natural inducible promoters toward engineered regulatory systems that integrate promoter remodeling, transcription factor engineering, computational design, high-throughput screening, and direct-acting promoter screening. This review systematically outlines recent progress in engineered chemically inducible gene regulatory systems, while maintaining a particular focus on promoter-centered design, focusing on five core design principles, including orthogonality, reversible responsiveness, dose dependence, modular compatibility, and sequence-dependent structural regulation. We highlight emerging strategies such as AI-driven promoter prediction, direct-acting DNA-based switches (G-quadruplex systems), and engineered receptor pathways that expand chemical sensing beyond classical transcription factors. Furthermore, we examine cutting-edge applications in metabolic pathway optimization, precision gene therapy, biosensor development, and programmable synthetic circuits, illustrating how chemically inducible promoters enable context-aware biological control. Despite challenges related to inducer permeability, cross-talk, and scalability, future progress is anticipated through the development of trace-free inducers, AI-assisted orthogonal system design, and autonomous regulation strategies for industrial scalability. Together, these advances establish chemically inducible promoters as foundational components of next-generation synthetic biology, bridging chemistry, computation, and engineering to drive innovations in biomanufacturing, therapeutics, and intelligent cellular systems.